Patents by Inventor Maura Murphy

Maura Murphy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSTION CONTAINING ACETOMINOPHEN AND IBUPROFEN
    Publication number: 20240091160
    Abstract: Solid oral dosage forms containing 325 mg of acetaminophen and 97.5 mg of ibuprofen or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 1 and 9 ?m, are described.
    Type: Application
    Filed: November 22, 2023
    Publication date: March 21, 2024
    Inventors: Maura Murphy, Matt Callahan
  • Pharmaceutical composition containing acetominophen and ibuprofen
    Patent number: 11872317
    Abstract: Solid oral dosage forms containing 325 mg of acetaminophen and 97.5 mg of ibuprofen or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 1 and 9 ?m, are described.
    Type: Grant
    Filed: December 22, 2022
    Date of Patent: January 16, 2024
    Assignee: AFT Pharmaceuticals Limited
    Inventors: Maura Murphy, Matt Callahan
  • PHARMACEUTICAL COMPOSTION CONTAINING ACETOMINOPHEN AND IBUPROFEN
    Publication number: 20230201125
    Abstract: Solid oral dosage forms containing 325 mg of acetaminophen and 97.5 mg of ibuprofen or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 1 and 9 ?m, are described.
    Type: Application
    Filed: December 22, 2022
    Publication date: June 29, 2023
    Inventors: Maura Murphy, Matt Callahan
  • Pharmaceutical compostion containing acetominophen and ibuprofen
    Patent number: 11534407
    Abstract: Solid oral dosage forms containing 325 mg of acetaminophen and 97.5 mg of ibuprofen or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 1 and 9 ?m, are described.
    Type: Grant
    Filed: December 13, 2021
    Date of Patent: December 27, 2022
    Inventors: Maura Murphy, Matt Callahan
  • PHARMACEUTICAL COMPOSTION CONTAINING ACETOMINOPHEN AND IBUPROFEN
    Publication number: 20220175680
    Abstract: Solid oral dosage forms containing 325 mg of acetaminophen and 97.5 mg of ibuprofen or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 1 and 9 ?m, are described.
    Type: Application
    Filed: December 13, 2021
    Publication date: June 9, 2022
    Inventors: Maura Murphy, Matt Callahan
  • Pharmaceutical composition containing acetaminophen and ibuprofen
    Patent number: 11197830
    Abstract: Solid oral dosage forms containing 325 mg of acetaminophen and 97.5 mg of ibuprofen or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 1 and 9 ?m, are described.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: December 14, 2021
    Inventors: Maura Murphy, Matt Callahan
  • PHARMACEUTICAL COMPOSTION CONTAINING ACETOMINOPHEN AND IBUPROFEN
    Publication number: 20200268673
    Abstract: Solid oral dosage forms containing 325 mg of acetaminophen and 97.5 mg of ibuprofen or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 1 and 9 ?m, are described.
    Type: Application
    Filed: February 27, 2019
    Publication date: August 27, 2020
    Inventors: Maura Murphy, Matt Callahan
  • Abiraterone Acetate Formulation and Methods of Use
    Publication number: 20190008874
    Abstract: Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.
    Type: Application
    Filed: July 10, 2018
    Publication date: January 10, 2019
    Inventors: Maura Murphy, Paul Nemeth, H. William Bosch, Matthew Callahan, Satya Bhamidipati, Jason Coleman, Christopher Hill, Marck Norret
  • Abiraterone acetate formulation and methods of use
    Patent number: 9889144
    Abstract: Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: February 13, 2018
    Assignee: iCeutica Inc.
    Inventors: Maura Murphy, Paul Nemeth, H. William Bosch, Matthew Callahan, Satya Bhamidipati, Jason Coleman, Christopher Hill, Marck Norret
  • Abiraterone Acetate Formulation and Methods of Use
    Publication number: 20170348328
    Abstract: Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.
    Type: Application
    Filed: July 10, 2017
    Publication date: December 7, 2017
    Inventors: Maura Murphy, Paul Nemeth, H. William Bosch, Matthew Callahan, Satya Bhamidipati, Jason Coleman, Christopher Hill, Marck Norret
  • Abiraterone Acetate Formulation and Methods of Use
    Publication number: 20150246060
    Abstract: Pharmaceutical compositions, including unit dosage forms, comprising abiraterone acetate and methods for producing and using such compositions are described.
    Type: Application
    Filed: May 8, 2015
    Publication date: September 3, 2015
    Inventors: Maura Murphy, Paul Nemeth, H. William Bosch, Matthew Callahan, Satya Bhamidipati, Jason Coleman, Christopher Hill
  • Immediate release dosage forms of sodium oxybate
    Patent number: 8771735
    Abstract: The present invention provides a pharmaceutical composition, presented as a solid unit dosage form adapted for oral administration of sodium oxybate. The preferred unit dosage form is a tablet comprising a relatively high weight-percentage of sodium oxybate, in combination with a relatively small weight-percentage of total excipients. This permits the tablets to contain/deliver a pharmaceutically effective amount, e.g., about 0.5-1.5 g of sodium oxybate in each tablet with a delivery profile similar to that of the liquid form. The tablets are bioequivalent to the liquid form.
    Type: Grant
    Filed: November 4, 2008
    Date of Patent: July 8, 2014
    Assignee: Jazz Pharmaceuticals, Inc.
    Inventors: Andrea Rourke, Clark Allphin, Maura Murphy
  • IMMEDIATE RELEASE DOSAGE FORMS OF SODIUM OXYBATE
    Publication number: 20100112056
    Abstract: The present invention provides a pharmaceutical composition, presented as a solid unit dosage form adapted for oral administration of sodium oxybate. The preferred unit dosage form is a tablet comprising a relatively high weight-percentage of sodium oxybate, in combination with a relatively small weight-percentage of total excipients. This permits the tablets to contain/deliver a pharmaceutically effective amount, e.g., about 0.5-1.5 g of sodium oxybate in each tablet with a delivery profile similar to that of the liquid form. The tablets are bioequivalent to the liquid form.
    Type: Application
    Filed: November 4, 2008
    Publication date: May 6, 2010
    Inventors: Andrea Rourke, Clark Allphin, Maura Murphy
  • Pharmaceutical compositions
    Publication number: 20060089385
    Abstract: Forms and formulations of VX-950 and uses thereof.
    Type: Application
    Filed: June 8, 2005
    Publication date: April 27, 2006
    Inventors: Yong Cui, Maura Murphy, Kirk Dinehart, Patricia Hurter, Patrick Connelly